Explore 3 Stock Ideas & Industry Insights Download Free Report

MedX Health Corp

Company price
0.04 CAD -0.01 ( 20.00%)
Last update at 2026-11-05T15:31:00Z
VOLUME
276100
Market Cap
18.04M

Momentum Score

…

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It also provides scope kits, SIAscope, a clinical camera; and DermSecure, a telemedicine software application. In addition, the company offers MedX rehab console system, rehab portable laser, and home unit; OraLase, a dental PBM laser; and veterinary-specific lasers. MedX Health Corp was incorporated in 1999 and is headquartered in Mississauga, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.04
Low
0.05
High
52 Week Price Range
0.05
Low
0.10
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

MedX Health Corp is a Canada-based company listed on the TSX Venture Exchange (MDX.V); publicly available details about its current operations are limited. Long-term growth may depend on commercializing its technology or service offerings, achieving market adoption and strategic partnerships.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.05
Dividend Yield
-
Revenue TTM
0.52M
Revenue Per Share
0.00
Gross Profit TTM
0.18M
Debt / Equity
-
ROE
-
Net Debt
6.82M
ROCE
30.93%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -3.65M -4.58M -5.13M -5.32M -3.20M
Net income -3.65M -4.58M -5.13M -5.32M -3.20M
Selling general administrative 1.67M 2.22M 2.94M 3.55M 2.79M
Gross profit 0.19M 0.19M 0.24M 0.29M 0.27M
Reconciled depreciation 0.05M 0.05M 0.05M 0.05M 0.08M
Ebit - - - - -3.03M
Ebitda - - -3.81M -4.49M -3.06M
Operating income -2.30M -3.03M -3.87M -4.56M -3.03M
Interest expense 1.35M 2.15M 1.27M 0.78M 0.06M
Net interest income -1.35M -2.15M -1.27M -0.78M -0.06M
Total revenue 0.49M 0.46M 0.51M 0.56M 0.53M
Total operating expenses 2.79M 3.48M 4.38M 5.13M 3.56M
Cost of revenue 0.30M 0.27M 0.27M 0.27M 0.26M
Total other income expense net - 0.60M 0.00M 0.02M -0.11M
Net income from continuing ops -3.65M -4.58M -5.13M -5.32M -3.20M
Net income applicable to common shares - - - - -3.20M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.88M 0.69M 0.68M 0.73M 0.73M
Total liab 9.41M 7.83M 7.76M 4.36M 2.80M
Total stockholder equity -8.52M -7.14M -7.08M -3.63M -2.07M
Other current liab - - - 0.62M 0.59M
Common stock - - - - 23.00M
Capital stock 27.49M 26.95M 23.96M 23.94M 23.00M
Retained earnings -54.50M -50.85M -46.27M -41.14M -35.81M
Cash 0.16M 0.14M 0.14M 0.11M 0.04M
Total current liabilities 8.33M 6.95M 6.88M 1.97M 2.57M
Net debt 6.82M 5.62M 4.86M 2.47M 0.88M
Short long term debt 5.90M 4.91M 4.12M 0.19M 0.68M
Other stockholder equity - - - - 2.41M
Property plant equipment - - - - 0.22M
Total current assets 0.84M 0.60M 0.54M 0.54M 0.51M
Net tangible assets - - - - -2.07M
Net receivables 0.03M 0.01M 0.01M 0.01M 0.04M
Long term debt 1.08M 0.84M 0.88M 2.39M 0.23M
Inventory 0.38M 0.34M 0.38M 0.37M 0.37M
Accounts payable 0.34M 0.63M 0.62M 0.50M 0.56M
Non current assets total 0.04M 0.09M 0.14M 0.19M 0.22M
Capital lease obligations 0.04M 0.09M - - 0.03M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 0.00M 0.00M 0.00M -0.02M -0.01M
Change to liabilities - - - 0.00M -0.13M
Total cashflows from investing activities - - - - -0.01M
Net borrowings 2.10M 2.95M - - -0.04M
Total cash from financing activities 2.53M 3.42M 2.84M 4.60M 2.94M
Change to operating activities - - - - -0.01M
Net income -3.65M -4.58M -5.13M -5.32M -3.20M
Change in cash 0.02M -0.00M 0.04M 0.07M 0.03M
Begin period cash flow 0.14M 0.14M 0.11M 0.04M 0.01M
End period cash flow 0.16M 0.14M 0.14M 0.11M 0.04M
Total cash from operating activities -2.51M -3.42M -2.80M -4.52M -2.91M
Issuance of capital stock 0.43M 0.41M 0.00M 0.93M 2.98M
Depreciation 0.05M 0.05M 0.05M 0.05M 0.08M
Change to inventory -0.04M 0.16M -0.01M 0.00M -0.13M
Change to account receivables -0.02M -0.06M -0.13M -0.03M 0.02M
Other cashflows from financing activities - - - 0.22M 0.22M
Change to netincome - - - - 0.46M
Capital expenditures 0.00M 0.00M 0.00M 0.02M 0.01M
Change in working capital 0.19M -0.13M 1.02M 0.04M -0.26M
Stock based compensation 0.14M 0.31M 0.33M 0.23M 0.35M
Other non cash items 1.35M 2.12M 1.27M 0.51M 0.02M
Free cash flow -2.51M -3.42M -2.80M -4.53M -2.91M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MDX
MedX Health Corp
-0.01
20.00%
0.04 - 13.50 34.49 - 53.75 -3.78
TLT
Theralase Technologies Inc.
0.01
2.70%
0.19 - - 90.07 82.51 90.31 -12.06
CNVI
Conavi Medical Corp.
-0.01
4.55%
0.10 - - 66.65 - 95.30 -
PINK
Perimeter Medical Imaging AI Inc
-0.02
11.11%
0.16 4.13 - 18.78 11.34 20.22 -2.55
CHER
Cheelcare Inc.
-0.03
2.40%
1.22 - - 20.92 106.42 21.26 -

Profile*

MedX Health Corp

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It also provides scope kits, SIAscope, a clinical camera; and DermSecure, a telemedicine software application. In addition, the company offers MedX rehab console system, rehab portable laser, and home unit; OraLase, a dental PBM laser; and veterinary-specific lasers. MedX Health Corp was incorporated in 1999 and is headquartered in Mississauga, Canada.

1495 Bonhill Road, Mississauga, ON, Canada, L5T 1M2

905 670 4428

Name Title Year Born
Mr. Louie Canitano COO & MD of Light Therapy Products NA
Mr. Michael Druhan Pres of Dermatological Services & Products NA
Mr. Naman Demaghlatrous BAMA Pres, CEO & Director NA
C H Freeman Interim Chief Financial Officer NA
Mr. Paul Karam Sales and Marketing Director of Europe, Middle East & Africa NA
Dr. Daniel A. Kaute Managing Director of Europe NA
Mr. Scott Naughton Managing Director of US Operations NA
Mr. Christopher H. Freeman Sec. NA
Mr. Christopher H. Freeman Corporate Secretary & Acting CFO NA
Mr. Michael Druhan President of Dermatological Services & Products NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…